Home LiteratureArticle Details
PMID: 14619979 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Regulation of matrix metalloproteinases: an overview.

Molecular and cellular biochemistry ·Vol. 253 ·No. 1-2 ·2003-11-00 ·Pages 269-85

Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T

Abstract

Matrix metalloproteinases (MMPs) are a major group of enzymes that regulate cell-matrix composition. MMP genes show a highly conserved modular structure. Ample evidence exists on the role of MMPs in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, cardiovascular diseases, pulmonary diseases and cancer. The expression patterns of MMPs have interesting implications for the use of MMP inhibitors as therapeutic agents. Insights might be gained as to the preference for a general MMP inhibitor as opposed to an inhibitor designed to be specific for certain MMP family members as it relates to a defined disease state, and may give clues to potential side effects. The signalling pathways that lead to induction of expression of MMPs are still incompletely understood, but certain patterns are beginning to emerge. Regarding inhibition of MMP expression at the level of kinase pathways, it is possible that selective chemical inhibitors for distinct signalling pathways (e.g. MAPK, PKC) will hopefully, soon be available for initial clinical trials. Overexpression of selective dual specificity MAPK phosphatases have been shown to prevent MMP promoter activation which could also be used as a novel strategy to prevent activation of AP-1 and ETS transcription factors and MMP promoters in vivo. Interactions between members of different transcription factors provide fine-tuning of the transcriptional regulation of MMP promoter activity. MMPs play a crucial role in tumor invasion. Although the expression of MMPs in malignancies has been studied widely, the specific role of distinct MMPs in the progression of cancer may be more complex than has been assumed. For example, it has recently been shown that MMP-3, MMP-7, MMP-9 and MMP-12 can generate angiostatin from plasminogen, indicating that their expression in peritumoral area may in fact serve to limit angiogenesis and thereby inhibit tumor growth and invasion. The recent view about the role of stromal cells in the progression of cancer cell growth and metastasis is particularly interesting, and additional studies about the regulation of MMP gene expression and activity in malignancies are needed to understand the role and regulation of MMPs in tumor cell invasion.

MeSH Terms
Animals Cell Compartmentation/physiology Cysteine/metabolism Enzyme Activation/physiology Humans MAP Kinase Signaling System/physiology Matrix Metalloproteinases/metabolism Nitric Oxide/metabolism Signal Transduction/physiology Tissue Inhibitor of Metalloproteinases/metabolism Transcription Factor AP-1/metabolism
Chemicals
Tissue Inhibitor of Metalloproteinases Transcription Factor AP-1 Nitric Oxide Matrix Metalloproteinases Cysteine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Chakraborti Sajal
Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India. s_chakraborti@hotmail.com
Mandal Malay
Das Sudip
Mandal Amritlal
Chakraborti Tapati
References (128)
128 references, click to expand
  1. Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms.
    Eur J Biochem. 1990 Apr 30;189(2):295-300 PMID: 2159879
  2. The AP-1 site and MMP gene regulation: what is all the fuss about?
    Matrix Biol. 1997 Mar;15(8-9):519-26 PMID: 9138284
  3. Transformation of mammalian cells by constitutively active MAP kinase kinase.
    Science. 1994 Aug 12;265(5174):966-70 PMID: 8052857
  4. Matrix metalloprotease 2-mediated activation of Ca(2+)-ATPase by superoxide radical (O2*-) in plasma membrane of bovine pulmonary vascular smooth muscle.
    Indian J Biochem Biophys. 2002 Dec;39(6):390-6 PMID: 22905396
  5. Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A.
    Biochem Biophys Res Commun. 1990 May 16;168(3):1171-6 PMID: 2161216
  6. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation.
    J Biol Chem. 2000 Aug 25;275(34):26416-22 PMID: 10827176
  7. Mitogen-activated protein kinase pathways.
    Curr Opin Cell Biol. 1997 Apr;9(2):180-6 PMID: 9069255
  8. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization.
    J Biol Chem. 1999 Oct 15;274(42):30087-93 PMID: 10514495
  9. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Cancer Res. 1996 Jun 15;56(12):2707-10 PMID: 8665498
  10. Regulation of proteolytic activity in tissues.
    Crit Rev Biochem Mol Biol. 1994;29(5):315-83 PMID: 7828434
  11. Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-beta site.
    J Biol Chem. 1997 May 2;272(18):11840-9 PMID: 9115242
  12. Differential glucocorticoid regulation of collagen mRNAs in human dermal fibroblasts. Keloid-derived and fetal fibroblasts are refractory to down-regulation.
    J Biol Chem. 1989 Aug 15;264(23):13730-5 PMID: 2760040
  13. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.
    J Biol Chem. 1991 Jul 25;266(21):14064-71 PMID: 1649834
  14. TNF-R55-specific form of human tumor necrosis factor-alpha induces collagenase gene expression by human skin fibroblasts.
    J Invest Dermatol. 1995 Aug;105(2):197-202 PMID: 7636301
  15. The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products.
    J Biol Chem. 1987 Apr 25;262(12):5886-9 PMID: 3032947
  16. Hyperexpression of mitogen-activated protein kinase in human breast cancer.
    J Clin Invest. 1997 Apr 1;99(7):1478-83 PMID: 9119990
  17. Matrix metalloproteinases: a review.
    Crit Rev Oral Biol Med. 1993;4(2):197-250 PMID: 8435466
  18. Low molecular weight, sequence based, collagenase inhibitors selectively block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases).
    Matrix. 1990 Oct;10(5):292-9 PMID: 1964713
  19. Human neutrophil collagenase.
    Matrix Suppl. 1992;1:31-6 PMID: 1480044
  20. Hormone receptors.
    N Engl J Med. 1979 Nov 22;301(21):1149-61 PMID: 226885
  21. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
    J Biol Chem. 1988 May 15;263(14):6579-87 PMID: 2834383
  22. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
    J Biol Chem. 2000 Aug 25;275(34):26411-5 PMID: 10827175
  23. Human monocytes/macrophages release TNF-alpha in response to Ox-LDL.
    Arterioscler Thromb Vasc Biol. 1996 Dec;16(12):1573-9 PMID: 8977464
  24. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Oncogene. 1997 Mar 27;14 (12 ):1481-93 PMID: 9136992
  25. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.
    Cell. 1990 Sep 21;62(6):1189-204 PMID: 2169351
  26. Signal transduction through MAP kinase cascades.
    Adv Cancer Res. 1998;74:49-139 PMID: 9561267
  27. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade.
    Science. 1998 Sep 11;281(5383):1668-71 PMID: 9733512
  28. Role of membrane-associated Ca+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+Atpase by tertiary butylhydroperoxide.
    Mol Cell Biochem. 2002 Aug;237(1-2):85-93 PMID: 12236590
  29. Regulation and function of the JNK subgroup of MAP kinases.
    Biochim Biophys Acta. 1997 Oct 24;1333(2):F85-104 PMID: 9395283
  30. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
    Biochemistry. 1993 Apr 27;32(16):4330-7 PMID: 8476862
  31. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions.
    Pharmacol Ther. 1993 Sep;59(3):329-41 PMID: 8309995
  32. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
    Cancer Res. 1996 Nov 15;56(22):5279-84 PMID: 8912869
  33. The ETS-domain transcription factor family.
    Int J Biochem Cell Biol. 1997 Dec;29(12):1371-87 PMID: 9570133
  34. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways.
    Science. 1988 Dec 9;242(4884):1424-7 PMID: 2462278
  35. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    J Biol Chem. 1996 Jul 19;271(29):17124-31 PMID: 8663255
  36. Matrix metalloproteinase gene expression.
    Ann N Y Acad Sci. 1994 Sep 6;732:42-50 PMID: 7978826
  37. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Cardiovasc Res. 2000 May;46(2):214-24 PMID: 10773225
  38. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors.
    Oncogene. 1997 Jun 5;14(22):2651-60 PMID: 9178763
  39. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.
    Mol Cell Biol. 1987 Jun;7(6):2256-66 PMID: 3037355
  40. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways.
    J Biol Chem. 1998 Feb 27;273(9):5137-45 PMID: 9478967
  41. NGF-induction of the metalloproteinase-transin/stromelysin in PC12 cells: involvement of multiple protein kinases.
    J Cell Biol. 1991 Sep;114(5):1037-48 PMID: 1908468
  42. Metalloproteinases in degenerative aortic disease.
    Clin Sci (Lond). 1991 Aug;81(2):233-9 PMID: 1653668
  43. Structure of the human type IV collagenase gene.
    J Biol Chem. 1990 Jul 5;265(19):11077-82 PMID: 2162831
  44. Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.
    J Biol Chem. 1994 Apr 8;269(14):10363-9 PMID: 8144618
  45. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.
    J Biol Chem. 1986 May 15;261(14):6600-5 PMID: 3009463
  46. Evidence that latent collagenases are enzyme-inhibitor complexes.
    Biochem J. 1977 May 1;163(2):303-7 PMID: 194584
  47. Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16.
    Genomics. 1990 Mar;6(3):554-9 PMID: 2158484
  48. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4322-6 PMID: 3012563
  49. A mammalian scaffold complex that selectively mediates MAP kinase activation.
    Science. 1998 Sep 11;281(5383):1671-4 PMID: 9733513
  50. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts.
    J Cell Biochem. 1992 Dec;50(4):400-10 PMID: 1469071
  51. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.
    Cell. 1994 Jun 17;77(6):841-52 PMID: 7911739
  52. Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts.
    Biochemistry. 1989 Oct 31;28(22):8691-8 PMID: 2605216
  53. Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells.
    Curr Biol. 1995 Aug 1;5(8):890-9 PMID: 7583147
  54. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.
    J Biol Chem. 1991 Feb 25;266(6):3893-9 PMID: 1847392
  55. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38.
    Matrix Biol. 1998 Dec;17 (8-9):547-57 PMID: 9923649
  56. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling.
    J Cell Sci. 1993 Apr;104 ( Pt 4):1001-11 PMID: 8314885
  57. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
    Int J Cancer. 1998 Jun 10;76(6):812-6 PMID: 9626346
  58. Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases.
    Cell Regul. 1990 Feb;1(3):269-78 PMID: 1966042
  59. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.
    J Biol Chem. 1991 Jul 15;266(20):13064-9 PMID: 2071592
  60. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
    FASEB J. 1991 May;5(8):2145-54 PMID: 1850705
  61. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
    Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82 PMID: 2164689
  62. Oxidative autoactivation of latent collagenase by human neutrophils.
    Science. 1985 Feb 15;227(4688):747-9 PMID: 2982211
  63. Matrix metalloproteinases in lung biology.
    Respir Res. 2001;2(1):10-9 PMID: 11686860
  64. Increasing complexity of Ras signal transduction: involvement of Rho family proteins.
    Adv Cancer Res. 1998;72:57-107 PMID: 9338074
  65. Structural biochemistry and activation of matrix metalloproteases.
    Curr Opin Cell Biol. 1993 Oct;5(5):891-7 PMID: 8240832
  66. Regulation of matrix metalloproteinase expression in tumor invasion.
    FASEB J. 1999 May;13(8):781-92 PMID: 10224222
  67. Matrix metalloproteinases in wound repair (review).
    Int J Mol Med. 2000 Oct;6(4):391-407 PMID: 10998429
  68. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
    Cell. 1996 May 31;85(5):683-93 PMID: 8646777
  69. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2.
    J Biol Chem. 2001 Mar 16;276(11):8403-8 PMID: 11113133
  70. Biology and biochemistry of proteinases in tumor invasion.
    Physiol Rev. 1993 Jan;73(1):161-95 PMID: 8419965
  71. Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli.
    Matrix Suppl. 1992;1:156-64 PMID: 1336108
  72. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.
    Cell. 1987 Jun 19;49(6):729-39 PMID: 3034432
  73. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.
    Cell. 1996 Aug 23;86(4):531-42 PMID: 8752208
  74. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    Oncogene. 1996 Sep 19;13(6):1323-33 PMID: 8808707
  75. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.
    Genes Dev. 2000 Jan 15;14(2):163-76 PMID: 10652271
  76. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability.
    Crit Rev Eukaryot Gene Expr. 1996;6(4):391-411 PMID: 8959374
  77. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
    J Clin Invest. 1996 Dec 1;98(11):2572-9 PMID: 8958220
  78. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.
    Mol Biol Cell. 2000 Oct;11(10):3353-64 PMID: 11029041
  79. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation.
    J Biol Chem. 1989 Jul 15;264(20):11539-42 PMID: 2473064
  80. TIMP-4 is regulated by vascular injury in rats.
    Circ Res. 1999 Mar 19;84(5):498-504 PMID: 10082471
  81. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene.
    Nucleic Acids Res. 1987 Feb 11;15(3):1139-51 PMID: 3547333
  82. Role of Ca2+-dependent metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in bovine pulmonary artery smooth muscle membrane.
    IUBMB Life. 2002 Mar;53(3):167-73 PMID: 12102173
  83. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms.
    Arterioscler Thromb. 1991 Nov-Dec;11(6):1667-77 PMID: 1931869
  84. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.
    Oncogene. 1995 Oct 5;11(7):1261-9 PMID: 7478546
  85. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.
    J Clin Invest. 1997 Mar 15;99(6):1210-6 PMID: 9077528
  86. How matrix metalloproteinases regulate cell behavior.
    Annu Rev Cell Dev Biol. 2001;17:463-516 PMID: 11687497
  87. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts.
    Biochemistry. 1991 May 7;30(18):4629-35 PMID: 1850629
  88. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries.
    Circulation. 1998 Jan 6-13;97(1):82-90 PMID: 9443435
  89. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300.
    Mol Cell Biol. 1996 Aug;16(8):4312-26 PMID: 8754832
  90. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
    Oncogene. 1996 Dec 5;13(11):2297-306 PMID: 8957070
  91. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7).
    J Biol Chem. 2000 Feb 11;275(6):4183-91 PMID: 10660581
  92. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2).
    Biochemistry. 1993 Feb 16;32(6):1583-92 PMID: 8431437
  93. Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation.
    Eur J Biochem. 1983 Jan 17;130(1):71-78 PMID: 6297897
  94. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels.
    J Immunol. 1997 Apr 1;158(7):3165-73 PMID: 9120270
  95. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
    Eur J Biochem. 1996 Jul 15;239(2):239-47 PMID: 8706726
  96. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains.
    Oncogene. 1998 Jun 25;16(25):3261-8 PMID: 9681824
  97. Transcriptional regulation of human stromelysin.
    J Biol Chem. 1989 May 15;264(14):8339-44 PMID: 2785989
  98. Lantent collagenase from human polymorphonuclear leucocytes and activation to collagenase by removal of a inhibitor.
    FEBS Lett. 1980 Oct 6;119(2):327-32 PMID: 6253328
  99. The stoichiometric activation of human skin fibroblast pro-collagenase by factors present in human skin and rat uterus.
    Arch Biochem Biophys. 1981 May;208(2):440-3 PMID: 6266348
  100. Matrix metalloproteinases: structures, evolution, and diversification.
    FASEB J. 1998 Sep;12(12):1075-95 PMID: 9737711
  101. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
    J Biol Chem. 1998 Sep 18;273(38):24360-7 PMID: 9733724
  102. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity.
    Am J Physiol. 1997 Aug;273(2 Pt 1):L445-50 PMID: 9277458
  103. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea.
    Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1779-88 PMID: 2170294
  104. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.
    EMBO J. 1994 Jul 1;13(13):3094-103 PMID: 8039503
  105. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity.
    Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2871-7 PMID: 10591663
  106. Cooperative interaction between Ets and AP-1 transcription factors regulates induction of glutathione S-transferase Ya gene expression.
    Biochem Biophys Res Commun. 1994 Apr 15;200(1):290-7 PMID: 8166697
  107. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.
    Biochem J. 1989 Aug 1;261(3):1031-4 PMID: 2803233
  108. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
    Cell. 1990 Sep 21;62(6):1217-26 PMID: 2169353
  109. Activation of human leucocyte procollagenase by rheumatoid synovial tissue culture medium.
    Ann Rheum Dis. 1975 Dec;34(6):520-3 PMID: 176958
  110. c-fos is required for malignant progression of skin tumors.
    Cell. 1995 Sep 8;82(5):721-32 PMID: 7545543
  111. Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin.
    Biochemistry. 1983 Jan 4;22(1):61-8 PMID: 6299336
  112. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.
    Cell. 1989 Dec 22;59(6):979-86 PMID: 2513128
  113. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
    J Biol Chem. 1989 Oct 15;264(29):17374-8 PMID: 2793861
  114. Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11.
    Genomics. 1988 Feb;2(2):119-27 PMID: 2900807
  115. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
    Proc Natl Acad Sci U S A. 1997 May 27;94(11):5826-30 PMID: 9159159
  116. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
    Circ Res. 1994 Jul;75(1):181-9 PMID: 8013077
  117. AP-1 function and regulation.
    Curr Opin Cell Biol. 1997 Apr;9(2):240-6 PMID: 9069263
  118. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
    Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57 PMID: 1751545
  119. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.
    J Clin Invest. 1993 Dec;92(6):2858-66 PMID: 8254040
  120. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes.
    J Biol Chem. 1991 Jun 25;266(18):11436-41 PMID: 1646806
  121. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.
    Cell. 1988 Jul 29;54(3):325-34 PMID: 2840203
  122. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):364-8 PMID: 2153297
  123. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.
    Cell. 1990 Sep 21;62(6):1205-15 PMID: 2169352
  124. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Nat Med. 1996 Jun;2(6):668-75 PMID: 8640558
  125. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3844-8 PMID: 8170999
  126. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation.
    EMBO J. 1998 Aug 3;17(15):4404-13 PMID: 9687508
  127. Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
    Cell Growth Differ. 1994 Nov;5(11):1205-13 PMID: 7848922
  128. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.
    Mol Cell Biol. 1990 Aug;10(8):4284-93 PMID: 2115124
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
Published
2003-11-00
Pages
269-85
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com